As of 2025-07-12, the EV/EBITDA ratio of Adapthealth Corp (AHCO) is -34.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AHCO's latest enterprise value is 3,154.61 mil USD. AHCO's TTM EBITDA according to its financial statements is -90.19 mil USD. Dividing these 2 quantities gives us the above AHCO EV/EBITDA ratio.
Range | Selected | |
Trailing P/E multiples | 9.3x - 11.3x | 11.1x |
Forward P/E multiples | 11.4x - 14.3x | 12.1x |
Fair Price | (20.36) - 46.83 | 7.86 |
Upside | -320.8% - 407.9% | -14.7% |
Date | EV/EBITDA |
2025-07-10 | -35.32 |
2025-07-09 | -35.01 |
2025-07-08 | -35.44 |
2025-07-07 | -35.02 |
2025-07-03 | -35.13 |
2025-07-02 | -35.20 |
2025-07-01 | -35.25 |
2025-06-30 | -35.29 |
2025-06-27 | -35.47 |
2025-06-26 | -35.28 |
2025-06-25 | -34.66 |
2025-06-24 | -34.29 |
2025-06-23 | -33.60 |
2025-06-20 | -33.74 |
2025-06-18 | -33.87 |
2025-06-17 | -33.92 |
2025-06-16 | -34.08 |
2025-06-13 | -34.05 |
2025-06-12 | -34.34 |
2025-06-11 | -34.28 |
2025-06-10 | -34.38 |
2025-06-09 | -34.38 |
2025-06-06 | -34.50 |
2025-06-05 | -34.68 |
2025-06-04 | -34.44 |
2025-06-03 | -34.44 |
2025-06-02 | -34.28 |
2025-05-30 | -34.62 |
2025-05-29 | -34.62 |
2025-05-28 | -34.77 |
2025-05-27 | -35.11 |
2025-05-23 | -34.32 |
2025-05-22 | -34.56 |
2025-05-21 | -34.74 |
2025-05-20 | -35.02 |
2025-05-19 | -34.63 |
2025-05-16 | -34.68 |
2025-05-15 | -34.71 |
2025-05-14 | -34.50 |
2025-05-13 | -34.69 |
2025-05-12 | -34.81 |
2025-05-09 | -34.01 |
2025-05-08 | -33.71 |
2025-05-07 | -33.51 |
2025-05-06 | -34.43 |
2025-05-05 | -34.20 |
2025-05-02 | -34.32 |
2025-05-01 | -33.90 |
2025-04-30 | -33.92 |
2025-04-29 | -33.71 |